Evidence map›Paper›PMID 32991408›Full record

Observational studyMedicine2020

Germinal ovarian tumors in reproductive age women: Fertility-sparing and outcome.

Miriam Dellino, Erica Silvestris, Vera Loizzi, Angelo Paradiso, Rosalia Loiacono, Carla Minoia, Antonella Daniele, Gennaro Cormio

Abstract readObservational Study
In one paragraph

Observational study in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. SARS-CoV-2 Vaccines and Adverse Effects in Gynecology and Obstetrics: The First Italian Retrospective Study.International journal of environmental research and public health · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Non-Epithelial Ovarian Cancers: How Much Do We Really Know?International journal of environmental research and public health · 2022
    Review
  17. Fertility-Sparing Surgery for Ovarian Cancer.Journal of clinical medicine · 2021
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Miriam DellinoGynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.ORCID 0000-0003-3522-4648
Erica SilvestrisGynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Vera LoizziDepartment of Biomedical Sciences and Human Oncology, Unit of Obstetrics and Gynaecology.
Angelo ParadisoIRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Rosalia LoiaconoGynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Carla MinoiaHaematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Antonella DanieleBiology Research, Department of Experimental Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Gennaro CormioDepartment of Biomedical Sciences and Human Oncology, Unit of Obstetrics and Gynaecology.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MOGCTs (malignant ovarian germ cell tumors) are rare tumors that mainly affect patients of reproductive age. The aim of this study was to evaluate the fertility and survival outcomes in young women with MOCGTs treated with fertility-sparing surgery (FSS).From 2000 to 2018, data from 28 patients of reproductive age with a diagnosis of MOGCT at the University of Bari were collected. Most received FSS, and in patients treated conservatively, the reproductive outcome and survival were investigated. Data of patient demographics, clinical presentation, oncology marker dosage, staging, type of surgery, histological examination, survival, and reproductive outcome were collected from hospital and office charts. All informed consent was obtained from all patients. The median age was 24 (range: 9-45 years). The majority of the patients had stage IIIC. Twenty-four woman received FSS consisting of unilateral ovariectomy and omentectomy, whereas only 4 women, based on their stage (IIIC), received a radical surgery (hysterectomy with bilateral adnexectomy, lymphadenectomy, and omentectomy). Our study shows that FSS in MOGCTs can produce good results both on reproductive outcomes and on survival. Indeed, in our group, there was only 1 case of exitus as result of recurrence. Furthermore, patients after FSS maintained normal ovarian function and 5 of 5 women who tried to get pregnant succeeded spontaneously. The median follow-up was 90 months (range 3-159).Conservative surgery for MOGCTs should be considered for women of reproductive age who wish to preserve fertility.

Indexed as

AdolescentAdultChildFemaleFertility PreservationHumansMiddle AgedNeoplasms, Germ Cell and EmbryonalNeoplasm StagingOvarian NeoplasmsYoung Adult

Identifiers

PMID32991408
PMCPMC7523774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.